Home

 

About me

 

Trainings

 

Experiences

 

Presentations

 

Publications

 

 

 

 

                                                                                                        

 

                              
 
 
Presentations

2007

1.      Barry K, Frantz C, Mirbolooki M, Mant M, Clarke G, Mirza I. JAK2 617V>F Mutation Correlates With Arterial Thrombosis in Essential Thrombocythemia. The 49th Annual Meeting of The American Society of Hematology. Atlanta, Georgia, US, December, 2007

2.      Kin T, Mirbolooki M, Salehi P, Tsukada M, O’Gorman D, Imes S, Ryan EA, Shapiro AM, Lakey JRT. Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using pre-oxygenated perfluorocarbon. Annual Meeting of Canadian Society of Transplantation, Banff, AB, Canada, March 2007

3.      Miszta-Lane H, Gill PJ, Chapman D, Mirbolooki M, Lakey JRT. High doses of glucose promotes differentiation of mesenchymal stem cells into insulin-positive cells, Annual Meeting of Canadian Society of Transplantation, Banff, AB, Canada, March 2007

2006

4.      Mirbolooki  M, Pawlick R, Shapiro AMJ, Lakey JRT. Limited oxygenation with the Two-Layer Method during pancreas preservation. 19th International Diabetes Federation Congress, Cape Town, South Africa, December 2006

5.      Mirbolooki  M, Miszta-Lane H, Pawlick R, Shapiro AMJ, Lakey JRT. Bubbling of oxygen in the University of Wisconsin solution during pancreas preservation improves islets survival. World Transplantation Congress, Boston, USA, July 2006

6.      Mirbolooki M, Kin T, Ryan E, Paty B, Senior P, Shapiro AMJ, Lakey JRT. Clinical Islet Transplantation: Five years experience of Edmonton Protocol in human pancreatic islet isolation. 13th Asia-Ocenia Congress of Endocrinology, Tehran, Iran, May 2006

7.      Mirbolooki M, Kin T, Ryan E, Shapiro AMJ, Lakey JRT. Intracellular ATP content of pancreatic tissue is a valuable predictor for the function of isolated human islets, Annual Meeting of Canadian Society of Transplantation, Mont-Tremblant, QC, Canada, March 2006

8.      Mirbolooki M, Shapiro AMJ, Lakey JRT. Failure of intraductal injection of oxygenated perfluorocarbon to improve islet survival for long-term pancreas preservation, 8th Internationa Congress of the Cell Transplant Society, Milan, Italy,  May 2006

9.      Harati H, Mirbolooki M, Hadaegh F, Padyab M, Azizi F. Determining a Practical Model for Primary Screening of Undiagnosed Diabetes in an Iranian Urban Population: Tehran Lipid and Glucose Study (TLGS). American Association of Clinical Endocrinologists, 15th Annual Meeting. April 26-30, 2006 Hyatt Regency Chicago, IL, Endocr Pract. 2006;12(Suppl 2) 25

10.  Kin T, Mirbolooki M, Brassil J, Shapiro AMJ, Lakey JRT. Machine perfusion for prolonged pancreas preservation prior to islet isolation. Montreal 2006

2005

11.  Mirbolooki M, Salehi P, Churchill TA, Lakey JRT. Hypothermia prior to the onset of pancreas procurement prevents pancreatic cell death. IPITA Geneva Switzerland 2005

12.  Mirbolooki M, Kin T, Mcghee-Wilson D, Richer B, O’Gorman D, Salehi P, Churchill TA, Shapiro AMJ, Lakey JRT. Improvement the islet yield in human pancreatic islet isolation by considering donor obesity and age. Annual Meeting of Canadian Society of Transplantation, Banff, Canada, 2005

13.  Salehi P, Mirbolooki M, Kin T, Tsujimura T, Shapiro AMJ, Churchill TA, Lakey JRT. Evaluation of human pancreatic energy metabolism during cold storage and islet isolation outcome following the two layer method preservation. IPITA Geneva Switzerland 2005

14.  Salehi P, Mirbolooki M, Kin T, Tsujimura T, Shapiro AMJ, Churchill TA, Lakey JRT. Ameliorating ischemic injury during preservation and isolation of human islet cells using the two layer method. AST Seattle, WA 2005

15.  Zhai X, Barnett M, Kin T, Mirbolooki M, Mcghee-Wilson D, Shapiro AMJ, Lakey JRT. Predictive analysis of tissue derived protease on human islet isolation. CST Banff 2005

16.  Salehi P, Lakey JR, Mirbolooki M, Tsukada M, Kin T, Shapiro AMJ, Churchill TA. Predicting the outcome of human islet isolation procedures. IPITA Geneva Switzerland 2005

2003

17.  Mirbolooki M, Ghanbili J, Asadian H, Mir Said Ghazi A.A, Azizi F. The rising prevalence of diabetes and impaired glucose tolerance in an Iranian population: Tehran Lipid and Glucose Study.18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

18.  Solati M, Mirbolooki M, Momenan A.A, Habibian S, Saadat N, Azizi F. Glycemic control and cardiovascular risk factors in Iranian patients with diabetes mellitus type 2: Tehran Lipid and Glucose Study18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

19.  Mirmiran P, Mirbolooki M, Hedayati M, Rahmani M, Azizi F. Prevalence of cardiovascular risk factors among Iranian adults with positive family history of diabetes mellitus: Tehran Lipid and Glucose Study.18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

20.  Ghanbarian A, Mirbolooki M, Momenan A.A, Hajipour H, Azizi F. Clustering of cardiovascular risk factors in middle aged Iranian subjects with impaired glucose tolerance: Tehran Lipid and Glucose Study. 18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

21.  Etemadi A, Mirbolooki M, Saadat N, Zahedi-Asl S, Azizi F. Development of diabetes mellitus in metabolic syndrome: Tehran Lipid and Glucose Study.18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

22.  Ainy A, Mirbolooki M, Zahedi-Asl S, Hajipour R, Azizi F. Familial clustering of diabetes Type 2 in an urban population of Iranian couples: Tehran family study.18th International Diabetes Federation Congress, 24-29 August 2003, Paris-France.

23.  Mirmiran P, Mirbolooki M, Rahmani M, Azizi F. Dietary assessment in urban population of Tehran: Tehran lipid and glucose study. 9th European Nutrition Conference, 1-4 October 2003, Rome – Italy.

24.  Saadat N, Mirbolooki M, Emami H, Salehi P, Azizi F. Fasting plasma glucose as a screening test for diabetes in an Iranian adult population; Tehran lipid and glucose study. 6 th European Congress of Endocrinology, 26-30 April 2003, Lyon – France.

25.  Etemadi A, Saadat N, Mirbolooki M, Zahedi Asl S, Azizi F. Metabolic syndrome and development of diabetes mellitus. 6th IEAane Eastern Mediterran Regional scientific Meeting, 9-11 December 2003, Ahwaz, Iran.

26. Mirbolooki M, Mirmiran P, Azizi F. Familial Clustering of obesity and the role of nutrition: Tehran Lipid and Glucose Study. 12th Asia Oceania Congress of Endocrinology, 20-24 September 2002, Taipei, Taiwan.